• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Addus HomeCare Announces Fourth Quarter and Year End 2024 Financial Results

    2/24/25 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care
    Get the next $ADUS alert in real time by email

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2024.

    Fourth Quarter 2024 Highlights:

    • Net Service Revenues Grow 7.5% to $297.1 Million
    • Net Income of $19.5 Million, or $1.07 per Diluted Share
    • Adjusted Net Income per Diluted Share Increases 4.6% year-over-year to $1.38
    • Adjusted EBITDA Increases 10.3% year-over-year to $37.8 Million
    • Cash Flow from Operations of $10.4 Million
    • Completed acquisition of Gentiva personal care operations

    Overview

    Net service revenues were $297.1 million for the fourth quarter of 2024, a 7.5% increase compared with $276.4 million for the fourth quarter of 2023. Net income was $19.5 million for the fourth quarter of 2024, compared with $19.6 million for the fourth quarter of 2023, while net income per diluted share was $1.07 compared with $1.20 for the same period a year ago. Adjusted EBITDA increased 10.3% to $37.8 million for the fourth quarter of 2024 from $34.3 million for the fourth quarter of 2023. Adjusted net income was $25.2 million for the fourth quarter of 2024 compared with $21.6 million for the prior-year period, while adjusted net income per diluted share was $1.38 compared with $1.32 for the fourth quarter of 2023. Adjusted net income per diluted share for the fourth quarter of 2024 excludes gain on sale of assets of ($0.15), impact of lease impairment of $0.20, impact of retroactive New York rate increase of ($0.14), acquisition expenses of $0.29 and stock-based compensation expense of $0.11 (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

    For the full year 2024, net service revenues increased 9.1% to $1.15 billion from $1.06 billion for the prior-year period. Net income was $73.6 million for 2024 compared with $62.5 million for 2023, and net income per diluted share was $4.23 compared with $3.83 per diluted share. Adjusted EBITDA increased 15.9% to $140.3 million for 2024 from $121.0 million for 2023. Adjusted net income was $91.4 million for 2024 compared with $74.8 million for 2023, while adjusted net income per diluted share was $5.26 compared with $4.58 for the prior-year period.

    Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, "Our fourth quarter financial and operating performance marked a strong finish to another successful year for Addus. We achieved top-line revenue growth of 7.5%, and adjusted EBITDA was 10.3% higher for the fourth quarter of 2024 compared with the same period last year. For the year, revenues were up 9.1% to reach $1.15 billion, a new annual high for Addus. These results reflect robust demand for our home-based care services and our ability to meet this demand with our proven operating model across the care continuum.

    "Our personal care services have been the key driver of our business, accounting for 74.1% of our revenue for the fourth quarter. We achieved a 5.8% organic revenue growth rate in personal care over the fourth quarter last year, and our annual organic growth was 7.7%, reflecting both higher volumes and favorable reimbursement trends. Results for the fourth quarter included one month from our acquisition of the personal care operations of Gentiva, which closed on December 2, 2024. The consolidated financial results for the fourth quarter excluded the Company's operations in New York, in connection with our previously announced agreement with HCS-Girling to divest the Company's New York personal care operations and exit the state.

    "Our hospice services accounted for 19.9% of our business with solid organic revenue growth of 7.8% over the fourth quarter last year. We are pleased with the steady improvement in average daily census, patient days and revenue per patient day compared with the same period last year. We implemented changes to our sales leadership late in the third quarter which we believe will result in continued improvement in admission volumes. Our home health services, which is our smallest business segment, accounted for 6.0% of total revenue for the fourth quarter," added Allison.

    Cash and Liquidity

    As of December 31, 2024, the Company had cash of $98.9 million and bank debt of $223.0 million, with capacity and availability under its revolving credit facility of $577.7 million and $346.6 million, respectively. Net cash provided by operating activities was $10.4 million for the fourth quarter of 2024, and $116.4 million for the full year 2024, inclusive of a net $2.4 million in ARPA funds utilization and $5.5 million in ARPA funds proceeds, respectively.

    Allison continued, "We are fortunate to have the financial flexibility to invest in our business and pursue our strategic growth initiatives. Acquisitions continue to be an important part of our growth strategy, allowing us to expand our coverage capabilities and build scale in strategic markets. The Gentiva personal care operations represent the largest acquisition in our history, adding approximately $280 million in annualized revenues and significantly expanding our market coverage in seven states, including Arizona, Arkansas, California, and Tennessee, as well as Texas, Missouri, and North Carolina, which are new personal care markets for Addus. Notably, we are now the largest provider of personal care services in the state of Texas and the state of Arkansas. Our respective teams have done an exceptional job in planning for the operational changes associated with this acquisition, and we are pleased that the integration process is on schedule as we continue to provide quality home care services to clients of those operations.

    "We are optimistic that we will see additional acquisition opportunities in 2025. We will maintain our disciplined approach to acquisitions by identifying prospects that are a good strategic fit for Addus, and our primary focus will be on markets where we can leverage our personal care network and add clinical services. We believe having three levels of care provides a distinct competitive advantage for Addus in our markets and benefits the clients we serve and strengthens our ability to negotiate more effectively with payers.

    "We are extremely proud of the important work we are doing and our ability to execute our strategy with positive results. Addus has a strong value proposition that meets the growing demand for home-based care. We have significantly enhanced our market position in 2024 through both organic growth and strategic acquisitions, and we are well positioned for continued growth. We are especially grateful for our dedicated team of caregivers, who support our mission and continue to provide outstanding care and support for a growing number of patients and clients in the home. Working together, we look forward to the opportunities ahead for Addus in 2025 as we extend our market reach and deliver greater value to our shareholders," said Allison.

    Non-GAAP Financial Measures

    The information provided in this release includes adjusted net income, adjusted EBITDA, adjusted net income per diluted share and adjusted net service revenue, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, retroactive rate increases from New York and the retroactive impact from collective bargaining negotiations. The Company defines adjusted EBITDA as earnings before net interest expense, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, retroactive rate increases from New York and the retroactive impact from collective bargaining negotiations. The Company defines adjusted net income per diluted share as net income per share, adjusted for acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, retroactive rate increases from New York and the retroactive impact from collective bargaining negotiations. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted net income per share to net income per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted net income per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company's operating performance, to provide investors with insight and consistency in the Company's financial reporting and to present a basis for comparison of the Company's business operations among periods, and to facilitate comparison with the results of the Company's peers.

    Conference Call

    Addus will host a conference call on Tuesday, February 25, 2025, at 9:00 a.m. Eastern time. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on March 4, 2025, by dialing (877) 344-7529 (international dial-in number is (412) 317-0088) and entering pass code 3644763.

    A live broadcast of Addus HomeCare's conference call will be available under the Investor Relations section of the Company's website: www.addus.com. An online replay will also be available on the Company's website for one month, beginning approximately two hours following the conclusion of the live broadcast.

    Forward-Looking Statements

    Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as "preliminary," "continue," "expect," and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare's relationships with referral sources, increased competition for Addus HomeCare's services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any security breaches, cyber-attacks, loss of data or cybersecurity threats or incidents, and other risks set forth in the Risk Factors section in Addus HomeCare's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2024, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

    About Addus HomeCare

    Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare's consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare's payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 62,000 consumers through 257 locations across 23 states. For more information, please visit www.addus.com.

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Condensed Consolidated Statements of Income

    (amounts and shares in thousands, except per share data)

    (Unaudited)

     
    Income Statement Information:

    For the Three Months

    Ended December 31,

    For the Twelve Months

    Ended December 31,

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

     

     
    Net service revenues

    $

    297,144

     

    $

    276,351

     

    $

    1,154,599

     

    $

    1,058,651

     

    Cost of service revenues

     

    195,662

     

     

    183,938

     

     

    779,578

     

     

    718,775

     

     
    Gross profit

     

    101,482

     

     

    92,413

     

     

    375,021

     

     

    339,876

     

     

    34.2

    %

     

    33.4

    %

     

    32.5

    %

     

    32.1

    %

    General and administrative expenses

     

    71,356

     

     

    60,766

     

     

    258,800

     

     

    234,794

     

    Depreciation and amortization

     

    3,214

     

     

    3,677

     

     

    13,530

     

     

    14,126

     

    Total operating expenses

     

    74,570

     

     

    64,443

     

     

    272,330

     

     

    248,920

     

     
    Operating income

     

    26,912

     

     

    27,970

     

     

    102,691

     

     

    90,956

     

     
    Total interest expense, net

     

    698

     

     

    2,616

     

     

    3,338

     

     

    9,630

     

     
    Income before income taxes

     

    26,214

     

     

    25,354

     

     

    99,353

     

     

    81,326

     

    Income tax expense

     

    6,688

     

     

    5,776

     

     

    25,755

     

     

    18,810

     

     
    Net income

    $

    19,526

     

    $

    19,578

     

    $

    73,598

     

    $

    62,516

     

     
    Net income per diluted share:

    $

    1.07

     

    $

    1.20

     

    $

    4.23

     

    $

    3.83

     

     
     
    Weighted average number of common shares outstanding:

    Diluted

     

    18,294

     

     

    16,307

     

     

    17,380

     

     

    16,311

     

     
     
    Cash Flow Information:

    For the Three Months

    Ended December 31,

    For the Twelve Months

    Ended December 31,

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

     

     
    Net cash provided by operating activities

    $

    10,418

     

    $

    30,049

     

    $

    116,434

     

    $

    112,247

     

    Net cash (used in) investing activities

     

    (354,486

    )

     

    (5,302

    )

     

    (354,610

    )

     

    (119,236

    )

    Net cash provided by (used in) financing activities

     

    220,127

     

     

    (39,706

    )

     

    272,296

     

     

    (8,181

    )

     
    Net change in cash

     

    (123,941

    )

     

    (14,959

    )

     

    34,120

     

     

    (15,170

    )

    Cash at the beginning of the period

     

    222,852

     

     

    79,750

     

     

    64,791

     

     

    79,961

     

    Cash at the end of the period

    $

    98,911

     

    $

    64,791

     

    $

    98,911

     

    $

    64,791

     

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Condensed Consolidated Balance Sheets

    (Amounts in thousands)

    (Unaudited)

     

     

     

     

     

    December 31,

     

     

    2024

     

     

    2023

     
    Assets
     
    Current assets
    Cash

    $

    98,911

    $

    64,791

    Accounts receivable, net

     

    122,880

     

    115,499

    Prepaid expenses and other current assets

     

    38,591

     

    19,714

     
    Total current assets

     

    260,382

     

    200,004

     
    Property and equipment, net

     

    24,703

     

    24,011

     
    Other assets
    Goodwill

     

    970,558

     

    662,995

    Intangible assets, net

     

    109,643

     

    91,983

    Operating lease assets

     

    47,348

     

    45,433

    Total other assets

     

    1,127,549

     

    800,411

     
    Total assets

    $

    1,412,634

    $

    1,024,426

     
    Liabilities and stockholders' equity
     
    Current liabilities
    Accounts payable

    $

    27,176

    $

    26,183

    Accrued payroll

     

    62,053

     

    56,551

    Accrued expenses

     

    28,959

     

    33,236

    Operating lease liabilities - current portion

     

    12,800

     

    11,339

    Government stimulus advance

     

    11,239

     

    5,765

    Accrued workers compensation

     

    13,644

     

    12,043

    Total current liabilities

     

    155,871

     

    145,117

     
    Long-term debt, less current portion, net of debt issuance costs

     

    218,443

     

    124,132

    Long-term lease liability, less current portion

     

    41,883

     

    39,711

    Deferred tax liabilities, net

     

    25,820

     

    8,529

    Other long-term liabilities

     

    125

     

    243

    Total long-term liabilities

     

    286,271

     

    172,615

     
    Total liabilities

     

    442,142

     

    317,732

     
    Total stockholders' equity

     

    970,492

     

    706,694

     
    Total liabilities and stockholders' equity

    $

    1,412,634

    $

    1,024,426

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Net Service Revenue by Segment

    (Amounts in thousands)

    (Unaudited)

     

     

     

     

     

     

     

     

     

    For the Three Months

    Ended December 31,

     

    For the Twelve Months

    Ended December 31,

     

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

    Net Service Revenues by Segment
     
    Personal Care

    $

    220,328

    $

    204,491

    $

    856,581

    $

    794,718

    Hospice

     

    58,989

     

    54,741

     

    228,191

     

    207,155

    Home Health

     

    17,827

     

    17,119

     

    69,827

     

    56,778

    Total Revenue

    $

    297,144

    $

    276,351

    $

    1,154,599

    $

    1,058,651

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Key Statistical and Financial Data (Unaudited)

     

     

     

     

     

     

     

     

     

    For the Three Months

    Ended December 31,

     

    For the Twelve Months

    Ended December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     
     
    Personal Care
     
    States served at period end

     

    -

     

     

    -

     

     

    23

     

     

    21

     

    Locations at period end

     

    -

     

     

    -

     

     

    196

     

     

    156

     

    Average billable census - same store (1, 2)

     

    36,342

     

     

    38,078

     

     

    37,438

     

     

    38,521

     

    Average billable census - acquisitions (3)

     

    14,581

     

     

    -

     

     

    14,581

     

     

    -

     

    Average billable census total

     

    50,923

     

     

    38,078

     

     

    52,019

     

     

    38,521

     

    Billable hours (in thousands)

     

    8,210

     

     

    7,694

     

     

    31,309

     

     

    30,658

     

    Average billable hours per census per month (3)

     

    69.6

     

     

    67.2

     

     

    71.5

     

     

    66.2

     

    Billable hours per business day

     

    124,397

     

     

    118,366

     

     

    119,498

     

     

    117,915

     

    Revenues per billable hour

    $

    26.40

     

    $

    26.53

     

    $

    27.21

     

    $

    25.86

     

    Organic growth
    - Revenue

     

    5.8

    %

     

    11.2

    %

     

    7.7

    %

     

    12.1

    %

     
    Hospice
     
    Locations served at period end

     

    -

     

     

    -

     

     

    38

     

     

    39

     

    Admissions

     

    3,095

     

     

    3,326

     

     

    12,866

     

     

    12,902

     

    Average daily census

     

    3,472

     

     

    3,381

     

     

    3,461

     

     

    3,415

     

    Average discharge length of stay

     

    97.9

     

     

    97.8

     

     

    94.1

     

     

    94.4

     

    Patient days

     

    319,460

     

     

    311,015

     

     

    1,266,701

     

     

    1,203,522

     

    Revenue per patient day

    $

    185.95

     

    $

    176.01

     

    $

    181.08

     

    $

    175.43

     

    Organic growth
    - Revenue

     

    7.8

    %

     

    3.5

    %

     

    5.9

    %

     

    2.0

    %

    - Average daily census

     

    2.7

    %

     

    (1.1

    )%

     

    1.3

    %

     

    0.3

    %

     
    Home Health
     
    Locations served at period end

     

    -

     

     

    -

     

     

    24

     

     

    24

     

    New Admissions

     

    4,365

     

     

    4,654

     

     

    18,622

     

     

    16,251

     

    Recertifications

     

    3,249

     

     

    3,214

     

     

    13,047

     

     

    9,030

     

    Total Volume

     

    7,614

     

     

    7,868

     

     

    31,669

     

     

    25,281

     

    Visits

     

    99,803

     

     

    104,161

     

     

    422,516

     

     

    344,919

     

    Organic growth
    - Revenue

     

    1.6

    %

     

    (17.8

    )%

     

    (3.1

    )%

     

    (7.1

    )%

    - New admissions

     

    (6.2

    )%

     

    (10.3

    )%

     

    (3.0

    )%

     

    (9.8

    )%

    - Volume

     

    (3.2

    )%

     

    (9.2

    )%

     

    (1.9

    )%

     

    (7.2

    )%

     
    Percentage of Revenues by Payor:
     
    Personal Care
     
    State, local and other governmental programs

     

    54.2

    %

     

    50.5

    %

     

    53.3

    %

     

    50.4

    %

    Managed care organizations

     

    43.1

     

     

    46.4

     

     

    44.0

     

     

    46.2

     

    Private duty

     

    2.0

     

     

    1.9

     

     

    1.8

     

     

    2.0

     

    Commercial

     

    0.5

     

     

    0.8

     

     

    0.7

     

     

    0.8

     

    Other

     

    0.2

    %

     

    0.4

    %

     

    0.2

    %

     

    0.6

    %

     
    Hospice
     
    Medicare

     

    91.4

    %

     

    89.3

    %

     

    91.2

    %

     

    89.9

    %

    Commercial

     

    4.9

     

     

    6.3

     

     

    5.1

     

     

    6.0

     

    Managed care organizations

     

    3.5

     

     

    3.7

     

     

    3.3

     

     

    3.4

     

    Other

     

    0.2

    %

     

    0.7

    %

     

    0.4

    %

     

    0.7

    %

     
    Home Health
     
    Medicare

     

    69.2

    %

     

    68.8

    %

     

    69.5

    %

     

    72.3

    %

    Managed care organizations

     

    24.2

     

     

    25.5

     

     

    25.2

     

     

    22.2

     

    Commercial

     

    2.9

     

     

    4.4

     

     

    3.9

     

     

    4.4

     

    Other

     

    3.7

    %

     

    1.3

    %

     

    1.4

    %

     

    1.1

    %

    (1) The average billable census in acquisitions of 85 and 91 for the three and twelve months ended December 31, 2023, was reclassified to average billable census - same stores for comparability purposes.
    (2) Exited sites would have reduced same store census for the three and twelve months ended December 31, 2023, by 1,401 and 1,446, respectively. Exited stores would have reduced same store census for the twelve months ended December 31, 2024, by 964.
    (3) The average billable census and average billable hours per census per month for the three and twelve months ended December 31, 2024, were prorated for the date of the acquisition.

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Reconciliation of Non-GAAP Financial Measures

    (Amounts in thousands, except per share data)

    (Unaudited) (1)

     

     

     

     

     

     

     

     

     

    For the Three Months

    Ended December 31,

     

    For the Twelve Months

    Ended December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    Reconciliation of Adjusted EBITDA to Net Income: (1)
     
    Net income

    $

    19,526

     

    $

    19,578

     

    $

    73,598

     

    $

    62,516

     

     
    Interest expense, net

     

    698

     

     

    2,616

     

     

    3,338

     

     

    9,630

     

    (Gain) Loss on sale of assets

     

    (3,725

    )

     

    3

     

     

    (3,738

    )

     

    (2

    )

    Income tax expense

     

    6,688

     

     

    5,776

     

     

    25,755

     

     

    18,810

     

    Depreciation and amortization

     

    3,214

     

     

    3,677

     

     

    13,530

     

     

    14,126

     

    Impact of lease impairment

     

    4,968

     

     

    -

     

     

    4,968

     

     

    -

     

    Impact of retroactive New York rate increase

     

    (3,487

    )

     

    -

     

     

    (3,004

    )

     

    (868

    )

    Impact of retroactive collective bargaining negotiations

     

    -

     

     

    (1,338

    )

     

    -

     

     

    -

     

    Acquisition expenses

     

    7,031

     

     

    1,428

     

     

    14,678

     

     

    6,220

     

    Stock-based compensation expense

     

    2,858

     

     

    2,488

     

     

    11,165

     

     

    10,319

     

    Restructure and other non-recurring costs

     

    -

     

     

    27

     

     

    -

     

     

    269

     

    Adjusted EBITDA

    $

    37,771

     

    $

    34,255

     

    $

    140,290

     

    $

    121,020

     

     
     
    Reconciliation of Adjusted Net Income to Net Income: (2)
     
    Net income

    $

    19,526

     

    $

    19,578

     

    $

    73,598

     

    $

    62,516

     

     
    (Gain) Loss on sale of assets

     

    (3,725

    )

     

    3

     

     

    (3,738

    )

     

    (2

    )

    Impact of lease impairment

     

    4,968

     

     

    -

     

     

    4,968

     

     

    -

     

    Impact of retroactive New York rate increase

     

    (3,487

    )

     

    -

     

     

    (3,004

    )

     

    (868

    )

    Impact of retroactive collective bargaining negotiations

     

    -

     

     

    (1,338

    )

     

    -

     

     

    -

     

    Acquisition expenses

     

    7,031

     

     

    1,428

     

     

    14,678

     

     

    6,219

     

    Stock-based compensation expense

     

    2,858

     

     

    2,488

     

     

    11,165

     

     

    10,319

     

    Restructure and other non-recurring costs

     

    -

     

     

    27

     

     

    -

     

     

    269

     

    Tax Effect

     

    (1,958

    )

     

    (594

    )

     

    (6,240

    )

     

    (3,685

    )

     
    Adjusted Net Income

    $

    25,213

     

    $

    21,592

     

    $

    91,427

     

    $

    74,768

     

     
     
    Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3)
     
    Net income per diluted share

    $

    1.07

     

    $

    1.20

     

    $

    4.23

     

    $

    3.83

     

     
    (Gain) Loss on the sale of assets per diluted share

     

    (0.15

    )

     

    -

     

     

    (0.16

    )

     

    -

     

    Impact of lease impairment per diluted share

     

    0.20

     

     

    -

     

     

    0.21

     

     

    -

     

    Impact of retroactive New York rate increase per diluted share

     

    (0.14

    )

     

    -

     

     

    (0.13

    )

     

    (0.04

    )

    Impact of retroactive collective bargaining negotiations

     

    -

     

     

    (0.07

    )

     

    -

     

     

    -

     

    Acquisition expenses per diluted share

     

    0.29

     

     

    0.07

     

     

    0.63

     

     

    0.29

     

    Restructure and other non-recurring costs per diluted share

     

    -

     

     

    -

     

     

    -

     

     

    0.01

     

    Stock-based compensation expense per diluted share

     

    0.11

     

     

    0.12

     

     

    0.48

     

     

    0.49

     

     
    Adjusted net income per diluted share

    $

    1.38

     

    $

    1.32

     

    $

    5.26

     

    $

    4.58

     

     
    Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4)
     
    Net service revenues

    $

    297,144

     

    $

    276,351

     

    $

    1,154,599

     

    $

    1,058,651

     

     
    Revenues associated with the closure of certain sites

     

    (3,447

    )

     

    (23,158

    )

     

    (71,230

    )

     

    (92,877

    )

     
    Adjusted net service revenues

    $

    293,697

     

    $

    253,193

     

    $

    1,083,369

     

    $

    965,774

     

    Footnotes:
    (1) We define Adjusted EBITDA as earnings before net interest expense, other non-operating income, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, retroactive rate increases from New York and the retroactive impact from collective bargaining negotiations. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. Additionally, our calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. We believe that Adjusted EBITDA is useful to investors, management and others in evaluating the Company's operating performance, to provide investors with insight and consistency in the Company's financial reporting and to present a basis for comparison of the Company's business among periods, and to facilitate comparison with results of the Company's peers. Additionally, we believe that Adjusted EBITDA is a measure widely used by securities analysts, investors and others to evaluate the financial performance of other public companies. The financial results presented in accordance with U.S GAAP and a reconciliation of this non-GAAP measure included within our Annual Report on Form 10-K should be carefully evaluated.
    (2) We define Adjusted Net Income as net income before acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs, gain on the sale of assets, lease impairment, retroactive collective bargaining negotiations and retroactive rate increases from New York. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
    (3) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition expenses, stock-based compensation expense and restructure and other non-recurring costs, gain on the sale of assets, lease impairment, retroactive collective bargaining negotiations and retroactive rate increases from New York. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
    (4) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250224064978/en/

    Brian W. Poff

    Executive Vice President, Chief Financial Officer

    Addus HomeCare Corporation

    (469) 535-8200

    [email protected]

    Dru Anderson

    FINN Partners

    (615) 324-7346

    [email protected]

    Get the next $ADUS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADUS

    DatePrice TargetRatingAnalyst
    12/16/2024$150.00Mkt Outperform
    JMP Securities
    10/11/2024$150.00Overweight
    KeyBanc Capital Markets
    6/28/2024$136.00Outperform
    Macquarie
    4/23/2024$83.00Equal Weight → Underweight
    Barclays
    3/6/2024$88.00Equal Weight
    Barclays
    2/5/2024Outperform
    William Blair
    12/12/2023$105.00Outperform
    TD Cowen
    6/29/2022$101.00Buy
    Stifel
    More analyst ratings

    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • JMP Securities initiated coverage on Addus HomeCare with a new price target

      JMP Securities initiated coverage of Addus HomeCare with a rating of Mkt Outperform and set a new price target of $150.00

      12/16/24 6:21:27 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Addus HomeCare with a new price target

      KeyBanc Capital Markets initiated coverage of Addus HomeCare with a rating of Overweight and set a new price target of $150.00

      10/11/24 7:29:16 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Macquarie initiated coverage on Addus HomeCare with a new price target

      Macquarie initiated coverage of Addus HomeCare with a rating of Outperform and set a new price target of $136.00

      6/28/24 7:30:03 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Addus HomeCare to Participate in Upcoming Investor Conferences in May

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its participation at the following investor conferences in May: BofA Securities 2025 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 14, 2025. Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:20 a.m. Pacific Time / 11:20 a.m. Central Time on Wednesday, May 14, 2025. 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025. Dirk Allison, Chairman and Chief Executive Officer and Brian Poff, Executive Vice Pr

      5/6/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Financials

    Live finance-specific insights

    See more
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces Fourth Quarter and Year End 2024 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights: Net Service Revenues Grow 7.5% to $297.1 Million Net Income of $19.5 Million, or $1.07 per Diluted Share Adjusted Net Income per Diluted Share Increases 4.6% year-over-year to $1.38 Adjusted EBITDA Increases 10.3% year-over-year to $37.8 Million Cash Flow from Operations of $10.4 Million Completed acquisition of Gentiva personal care operations Overview Net service revenues were $297.1 million for the fourth quarter of 2024, a 7.5% increase compared with $276.4 milli

      2/24/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Addus HomeCare Corporation

      SC 13G - Addus HomeCare Corp (0001468328) (Subject)

      11/13/24 9:44:25 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      2/13/24 4:55:59 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      1/22/24 2:03:09 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Leadership Updates

    Live Leadership Updates

    See more
    • Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

      Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately. "Axonics is fortunate to have someone of Dr. López's character and extensive experience join our board of directors," said Raymond W. Cohen, CEO of Axonics. "Given his thought leadership in healthcare, Dr. López will be a valuable adviser to Axonics as we continue to execute on our ambitious growth objectives." Dr. López is the Americas healthcare and life sciences Market Lead at Google Cloud with multinational

      7/15/21 6:00:00 AM ET
      $AXNX
      $ADUS
      Medical/Dental Instruments
      Health Care
      Medical/Nursing Services
    • Addus HomeCare Announces Retirement of Laurie Manning

      Robby Stevenson Named Company's Chief Human Resource Officer Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that Laurie Manning retired from her position as Executive Vice President and Chief Human Resource Officer, effective June 11, 2021. Robby Stevenson, Senior Vice President of Human Resources, has been promoted to Executive Vice President and Chief Human Resource Officer and will assume leadership in that area. Commenting on the announcement, Dirk Allison, Chairman and Chief Executive Officer, said, "Laurie has played an important role in the growth and success of Addus since she joined the Company in 2017. Our employees are our most impor

      6/14/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Names Veronica Hill-Milbourne And Esteban López, M.D. To Board Of Directors

      FRISCO, Texas, Jan. 11, 2021 /PRNewswire/ -- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced that Veronica Hill-Milbourne and Esteban López, M.D. have been appointed to the Company's Board of Directors, effective January 11, 2021. Ms. Hill-Milbourne is President and Chief Executive Officer of Spectrum Health Services, Inc., with executive oversight of three Federally Qualified Health Centers located in Philadelphia, Pennsylvania. She previously served as Chief Executive Officer/State Director for Pathways by Atar Capital, with executive oversight of mental and behavioral health home and community-based service programs operating in 30 counties

      1/11/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP/Chief Development Officer Blessing Cliff Donald sold $18,008 worth of shares (178 units at $101.17), decreasing direct ownership by 2% to 10,401 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      4/22/25 4:30:22 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • EVP/Chief Financial Officer Poff Brian was granted 31,750 shares, increasing direct ownership by 96% to 64,719 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      3/12/25 4:00:12 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • CEO and Chairman Allison R Dirk was granted 63,500 shares, increasing direct ownership by 62% to 166,461 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      3/12/25 4:00:05 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    SEC Filings

    See more
    • SEC Form 10-Q filed by Addus HomeCare Corporation

      10-Q - Addus HomeCare Corp (0001468328) (Filer)

      5/6/25 4:30:26 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form 8-K filed by Addus HomeCare Corporation

      8-K - Addus HomeCare Corp (0001468328) (Filer)

      5/5/25 4:54:55 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Corporation filed SEC Form 8-K: Leadership Update

      8-K - Addus HomeCare Corp (0001468328) (Filer)

      3/11/25 4:12:41 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care